Page last updated: 2024-09-04

mk 767 and drf 2725

mk 767 has been researched along with drf 2725 in 3 studies

Compound Research Comparison

Studies (mk 767)	Trials (mk 767)	Recent Studies (post-2010) (mk 767)	Studies (drf 2725)	Trials (drf 2725)	Recent Studies (post-2010) (drf 2725)
32	0	10	41	3	4

Protein Interaction Comparison

Protein	Taxonomy	drf 2725 (IC50)
Chain A, peroxisome proliferator activated receptor gamma	Homo sapiens (human)	0.092
Peroxisome proliferator-activated receptor gamma	Homo sapiens (human)	0.092
Peroxisome proliferator-activated receptor alpha	Homo sapiens (human)	0.98

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Deussen, HJ; Ebdrup, S; Fleckner, J; Frost Jensen, A; Mortensen, SB; Nygaard, L; Pettersson, I; Pridal, L; Rasmussen, HB; Sauerberg, P	1
Henke, BR	1
Kagechika, K; Kubo, H; Shibata, Y; Usui, H; Yamaguchi, M	1

Reviews

1 review(s) available for mk 767 and drf 2725

Article	Year
Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes. Journal of medicinal chemistry, 2004, Aug-12, Volume: 47, Issue:17 Topics: Animals; Diabetes Mellitus, Type 2; Humans; Hyperglycemia; Hypoglycemic Agents; Models, Molecular; Molecular Structure; Receptors, Cytoplasmic and Nuclear; Transcription Factors	2004

Other Studies

2 other study(ies) available for mk 767 and drf 2725

Article	Year
Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar. Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8 Topics: Binding Sites; Crystallography, X-Ray; Hypoglycemic Agents; Ligands; Models, Molecular; Oxazines; Phenylpropionates; Radioligand Assay; Receptors, Cytoplasmic and Nuclear; Stereoisomerism; Transcription Factors	2003
Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1). Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23 Topics: Animals; Blood Glucose; Drug Design; Mice; PPAR alpha; PPAR gamma; Structure-Activity Relationship; Thiazolidinediones; Triglycerides; Weight Gain	2012

Article

Year

Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.

Journal of medicinal chemistry, 2003, Apr-10, Volume: 46, Issue:8

Topics: Binding Sites; Crystallography, X-Ray; Hypoglycemic Agents; Ligands; Models, Molecular; Oxazines; Phenylpropionates; Radioligand Assay; Receptors, Cytoplasmic and Nuclear; Stereoisomerism; Transcription Factors

2003

Design, synthesis and evaluation of novel zwitterionic compounds as PPARα/γ dual agonists (1).

Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

Topics: Animals; Blood Glucose; Drug Design; Mice; PPAR alpha; PPAR gamma; Structure-Activity Relationship; Thiazolidinediones; Triglycerides; Weight Gain

2012